156 related articles for article (PubMed ID: 4094901)
1. [New criteria for scintigraphic follow-up of bone metastases following radiotherapy. Results of functional scintigraphy using 99mTc-MDP].
Knop J; Stritzke P; Langendorff G
Nuklearmedizin; 1985 Dec; 24(5-6):238-43. PubMed ID: 4094901
[TBL] [Abstract][Full Text] [Related]
2. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
5. [Radiologic follow-up and prognosis of efficiency of systemic Sr-89 Cl-2 therapy of bone metastases in prostate cancer].
Barysheva EV; Obradovic V; Stefanovic L; Riannel' IuE; Regoe S; Selivanov SP; Artiko V; Isaeva SN; Velichko SA; Tuzikov SA; Ussov VIu
Vestn Rentgenol Radiol; 2000; (6):46-50. PubMed ID: 12717912
[TBL] [Abstract][Full Text] [Related]
6. [Uptake behavior of bone metastases of hypernephroma in the 99m Tc-MDP bone scintigram. A comparison with x-ray findings].
Steinbächer M; Rieden K; Bihl H; Georgi P
Rofo; 1987 May; 146(5):555-8. PubMed ID: 3035642
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
[TBL] [Abstract][Full Text] [Related]
8. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
[TBL] [Abstract][Full Text] [Related]
9. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
[TBL] [Abstract][Full Text] [Related]
10. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
12. [Bone scan "flare" in patients irradiated to formerly false negative bone metastasis].
Inoue Y; Ohtake T; Oyama K; Momose T; Watanabe T; Kosaka N; Nishikawa J; Sasaki Y
Kaku Igaku; 1991 Sep; 28(9):1091-8. PubMed ID: 1770662
[TBL] [Abstract][Full Text] [Related]
13. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
Matsuda H; Sakashita S; Arakawa M; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
[No Abstract] [Full Text] [Related]
14. Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer.
Chavdarova L; Piperkova E; Tsonevska A; Timcheva K; Dimitrova M
J BUON; 2006; 11(4):499-504. PubMed ID: 17309184
[TBL] [Abstract][Full Text] [Related]
15. [Bone scintigraphy in bone metastases due to prostatic cancer].
Hidaka H; Ishino Y; Nakayama C; Nakata H; Okamura T
J UOEH; 1987 Dec; 9(4):369-77. PubMed ID: 3438611
[TBL] [Abstract][Full Text] [Related]
16. [Radiologic diagnosis of bone metastases recurrence in patients with prostate cancer treated strontium-89].
Barysheva EV; Selivanov SP; Riannel' IuE; Velichko SA; Usynin EA; Usov VIu
Vestn Rentgenol Radiol; 1999; (5):32-6. PubMed ID: 12717923
[TBL] [Abstract][Full Text] [Related]
17. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
18. [A phosphine-substituted diphosphonic acid (HMPD) for improved scintigraphic detection of bone lesions].
Steinsträsser A; Schwarz A; Alexander C; Berberich R; Zimmer M
Nuklearmedizin; 1992 Oct; 31(5):164-71. PubMed ID: 1465353
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of 67Ga accumulation around the shoulder joint--comparison with 99mTc-MDP].
Kobayashi H; Tanaka K; Sakuma S
Kaku Igaku; 1991 Feb; 28(2):143-50. PubMed ID: 2051652
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
